117 related articles for article (PubMed ID: 38606696)
21. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of irritable bowel syndrome in young adult Malaysians: a survey among medical students.
Tan YM; Goh KL; Muhidayah R; Ooi CL; Salem O
J Gastroenterol Hepatol; 2003 Dec; 18(12):1412-6. PubMed ID: 14675271
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and Burden of Illness of Rome IV Irritable Bowel Syndrome in the United States: Results From a Nationwide Cross-Sectional Study.
Almario CV; Sharabi E; Chey WD; Lauzon M; Higgins CS; Spiegel BMR
Gastroenterology; 2023 Dec; 165(6):1475-1487. PubMed ID: 37595647
[TBL] [Abstract][Full Text] [Related]
24. Subtypes of irritable bowel syndrome in children and adolescents.
Self MM; Czyzewski DI; Chumpitazi BP; Weidler EM; Shulman RJ
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1468-73. PubMed ID: 24486406
[TBL] [Abstract][Full Text] [Related]
25. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
[TBL] [Abstract][Full Text] [Related]
26. Irritable bowel syndrome: a population based study.
Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
[TBL] [Abstract][Full Text] [Related]
27. Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults.
Kubo M; Fujiwara Y; Shiba M; Kohata Y; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
Neurogastroenterol Motil; 2011 Mar; 23(3):249-54. PubMed ID: 21122032
[TBL] [Abstract][Full Text] [Related]
28. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
[TBL] [Abstract][Full Text] [Related]
29. Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.
Patel P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P; Ford AC
Aliment Pharmacol Ther; 2015 Mar; 41(5):449-58. PubMed ID: 25586008
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome: a population-based survey in China.
Zhao YF; Guo XJ; Zhang ZS; Ma XQ; Wang R; Yan XY; He J
PLoS One; 2012; 7(8):e43749. PubMed ID: 22937091
[TBL] [Abstract][Full Text] [Related]
31. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
[TBL] [Abstract][Full Text] [Related]
32. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
Choghakhori R; Abbasnezhad A; Amani R; Alipour M
Dig Dis Sci; 2017 Jun; 62(6):1550-1560. PubMed ID: 28374085
[TBL] [Abstract][Full Text] [Related]
33. High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria.
Aziz I; Mumtaz S; Bholah H; Chowdhury FU; Sanders DS; Ford AC
Clin Gastroenterol Hepatol; 2015 Sep; 13(9):1650-5.e2. PubMed ID: 25769413
[TBL] [Abstract][Full Text] [Related]
34. Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities.
Kibune Nagasako C; Garcia Montes C; Silva Lorena SL; Mesquita MA
Rev Esp Enferm Dig; 2016 Feb; 108(2):59-64. PubMed ID: 26838486
[TBL] [Abstract][Full Text] [Related]
35. [Features of the course of irritable bowel syndrome in patients with excess body weight].
Bychkov MA; Ferents IM
Wiad Lek; 2018; 71(3 pt 2):688-690. PubMed ID: 29783248
[TBL] [Abstract][Full Text] [Related]
36. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.
Hod K; Ringel-Kulka T; Martin CF; Maharshak N; Ringel Y
J Clin Gastroenterol; 2016 Mar; 50(3):227-32. PubMed ID: 25930973
[TBL] [Abstract][Full Text] [Related]
37. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
[TBL] [Abstract][Full Text] [Related]
38. Natural history of irritable bowel syndrome.
Marugán-Miguelsanz JM; Ontoria M; Velayos B; Torres-Hinojal MC; Redondo P; Fernández-Salazar L
Pediatr Int; 2013 Apr; 55(2):204-7. PubMed ID: 23253156
[TBL] [Abstract][Full Text] [Related]
39. Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China.
Lv CL; Song GQ; Liu J; Wang W; Huang YZ; Wang B; Tian JS; Yin MQ; Yu Y
World J Gastroenterol; 2023 Nov; 29(41):5657-5667. PubMed ID: 38077156
[TBL] [Abstract][Full Text] [Related]
40. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
